Qiwen Shi

Education

Ph.D., Biomedical Sciences (Pharmacology)                                            2010.08-2015.08                           

Kent State University                                                                                 Kent, OH, USA

 B.S., Pharmacy                                                                                        2006.09-2010.07

China Pharmaceutical University                                                              Nanjing, China

Work Experience

Assistant Professor, Director of Pharmaceutical Engineering                   2015.12-present

Collaborative Innovation Center of Green Pharmaceuticals

Zhejiang University of Technology                                                            Hangzhou, China

Teaching Assistant                                                                                    2010.08-2015.08

Department of Biomedical Sciences

Kent State University                                                                                  Kent, OH, USA

Undergraduate Courses

Pharmacology

Labs in Pharmacology

Physiology

Human Anatomy

Graduate Courses

Advaced Pharmacology

• 1. Liu, F., Yang, C., Li, S., Wu, X., Xue, K., Zhou, Y., Liang, X., Cheng, X., Shi, Q., and Su, W. (2022). Design and biological features of platinum (II) complexes with 3-hydroxy-3-(Trifluoromethyl)cyclobutane-1,1-Dicarboxylate as a leaving ligand. European journal of medicinal chemistry 242, 114673. 

  2. Li, S., Li, B., Lang, K., Gong, Y., Cheng, X., Deng, S., Shi, Q., and Zhao, H. (2022). LncRNA MALAT1 Participates in Protection of High-Molecular-Weight Hyaluronan against Smoke-Induced Acute Lung Injury by Upregulation of SOCS-1. Molecules 27. 

  3. Liu, F., Cheng, X., Wu, S., Hu, B., Yang, C., Deng, S., and Shi, Q. (2022). Nickel oxide nanoparticles induce apoptosis and ferroptosis in airway epithelial cells via ATF3. Environ Toxicol 37, 1093-1103. 

  4. Shi, Q., Hu, B., Yang, C., Deng, S., Cheng, X., Wu, J., and Qi, N. (2021). ATF3 inhibits arsenic-induced malignant transformation of human bronchial epithelial cells by attenuating inflammation. Toxicology 460, 152890. 

  5. Shi, Q., Hu, B., Yang, C., Zhao, L., Wu, J., and Qi, N. (2021). ATF3 Promotes Arsenic-Induced Apoptosis and Oppositely Regulates DR5 and Bcl-xL Expression in Human Bronchial Epithelial Cells. International journal of molecular sciences 22. 

  6. Shi, Q., Sutariya, V., Varghese Gupta, S., and Bhatia, D. (2019). GADD45alpha-targeted suicide gene therapy driven by synthetic CArG promoter E9NS sensitizes NSCLC cells to cisplatin, resveratrol, and radiation regardless of p53 status. OncoTargets and therapy 12, 3161-3170. 

  7. Shi, Q., Zhao, L., Xu, C., Zhang, L., and Zhao, H. (2019). High Molecular Weight Hyaluronan Suppresses Macrophage M1 Polarization and Enhances IL-10 Production in PM2.5-Induced Lung Inflammation. Molecules 24. 

  8. Xu, C., Shi, Q., Zhang, L., and Zhao, H. (2018). High molecular weight hyaluronan attenuates fine particulate matter-induced acute lung injury through inhibition of ROS-ASK1-p38/JNK-mediated epithelial apoptosis. Environmental toxicology and pharmacology 59, 190-198. 

  9. Zhang, L., Xu, C., Chen, X., Shi, Q., Su, W., and Zhao, H. (2018). SOCS-1 Suppresses Inflammation Through Inhibition of NALP3 Inflammasome Formation in Smoke Inhalation-Induced Acute Lung Injury. Inflammation 41, 1557-1567.

  10. Zhang, L., Xu, C., Ma, Y., Zhu, K., Chen, X., Shi, Q., Su, W., and Zhao, H. SOCS-1 ameliorates smoke inhalation-induced acute lung injury through inhibition of ASK-1 activity and DISC formation. Clin Immunol 191, 94-99.